No Vacillation on HPV Vaccination

Douglas Sipp; Ian H Frazer; John E J Rasko

doi:10.1016/j.cell.2018.02.045

No Vacillation on HPV Vaccination

Cell. 2018 Mar 8;172(6):1163-1167. doi: 10.1016/j.cell.2018.02.045.

Authors

Douglas Sipp¹, Ian H Frazer², John E J Rasko³

Affiliations

¹ RIKEN Center for Developmental Biology, 2-2-3 Minatojima Minamimachi, Chuo-ku, Kobe, Japan; Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan; Keio Global Research Institute, 2 Chome-15-45 Mita, Minato-ku, Tokyo, Japan; RIKEN Center for Advanced Intelligence Project, Nihonbashi 1-chome Mitsui Building, 15th floor, 1-4-1 Nihonbashi, Chuo-ku, Tokyo 103-0027, Japan.
² Professor / Head, Cancer Immunology Program, UQDI, Faculty of Medicine, The University of Queensland, Level 6, East Wing, Translational Research Institute (TRI), 37 Kent Street, Woolloongabba QLD 4102, Australia.
³ Gene & Stem Cell Therapy Program, Centenary Institute, University of Sydney, Camperdown 2050, Australia; Sydney Medical School, University of Sydney, NSW 2006, Australia; Cell and Molecular Therapies, Royal Prince Alfred Hospital, Camperdown 2050, Australia. Electronic address: j.rasko@centenary.org.au.

PMID: 29522737
DOI: 10.1016/j.cell.2018.02.045

Abstract

Evidence of the safety and protective benefits of human papillomavirus virus (HPV) vaccines as an anti-cancer measure is overwhelming. However, vaccine uptake varies widely across countries and falls short of levels needed to achieve population immunity. We highlight policy measures that would help ensure greater worldwide coverage and save lives.

MeSH terms

Alphapapillomavirus / drug effects
Alphapapillomavirus / immunology*
Female
Global Health / trends
Humans
Papillomavirus Infections / immunology*
Papillomavirus Infections / prevention & control
Papillomavirus Infections / virology
Papillomavirus Vaccines / economics
Papillomavirus Vaccines / immunology*
Papillomavirus Vaccines / therapeutic use
Uterine Cervical Neoplasms / immunology*
Uterine Cervical Neoplasms / prevention & control
Uterine Cervical Neoplasms / virology
Vaccination / economics
Vaccination / methods
Vaccination / trends

Substances

Papillomavirus Vaccines